This project aims to study an innovative intervention, the eG2 Intervention, developed by speech-language pathologists at the Centre hospitalier de l'Université de Montréal to improve therapeutic adherence and prevent dysphagia in patients treated with chemoradiotherapy for head and neck cancer. The innovation consists in offering a speech therapy intervention that is 1) virtual, 2) group-based (whereas it is usually individual) and 3) involves a patient partner. This intervention has the potential to improve quality of care, accessibility to services and optimize health care resources.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
76
virtual group speech therapy intervention guided by a patient partner
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
RECRUITINGRate of nasogastric tube
To evaluate the rate of nasogastric tube placement in the acute and subacute period in patients who participated in the group intervention.
Time frame: within 6 weeks post radiation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.